SCHEMBL24203423

SCHEMBL24203423

CC(C)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@H](c1cc3c(cc1Br)OCO3)N2

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.74
L3MBTL1 Q9Y468 3/20 0.74
TDP1 Q9NUW8 2/20 0.74
KMT2A Q03164 6/20 0.74
MEN1 O00255 5/20 0.74
CYP1A2 P05177 1/20 0.74
CYP2C9 P11712 1/20 0.74
CYP2C19 P33261 1/20 0.74
GPER1 Q99527 3/20 0.72
GPR183 P32249 1/20 0.72
NPC1 O15118 1/20 0.72
RAB9A P51151 1/20 0.72
POLB P06746 4/20 0.72
LMNA P02545 2/20 0.72
HTT P42858 1/20 0.72
AR P10275 2/20 0.43
CHRNA7 P36544 1/20 0.43
ALDH1A1 P00352 3/20 0.41
USP2 O75604 2/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12701119 0.87 MAPT (0.81) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12700906 0.86 MAPT (0.78) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12722301 0.85 MAPT (1.00) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL916774 0.84 MAPT (0.73) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12700921 0.84 GPER1 (1.00) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12700948 0.84 GPER1 (1.00) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12700947 0.84 GPER1 (1.00) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12524898 0.84 GPER1 (1.00) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12700983 0.84 GPER1 (1.00) MAPTL3MBTL1TDP1KMT2AMEN1
SCHEMBL12700922 0.84 GPER1 (1.00) MAPTL3MBTL1TDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236074-B2 Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2022-02-01 US disclosed
US-20220017497-A1 COMPOSITIONS AND METHODS FOR DECREASING, OR PREVENTING OR REVERSING GAIN OF, SKIN PIGMENTATION IN A MAMMALIAN SUBJECT UNIV PENNSYLVANIA (US) 2022-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236074-B2 Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject MC1R, GPER1, NR2E3 MAPT 4810/4885L3MBTL1 4658/4885TDP1 3691/4885
US-20220017497-A1 COMPOSITIONS AND METHODS FOR DECREASING, OR PREVENTING OR REVERSING GAIN OF, SKIN PIGMENTATION IN A MAMMALIAN SUBJECT MC1R, GPER1, NR2E3 MAPT 4810/4885L3MBTL1 4658/4885TDP1 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.